Clinical Trials Logo

Hemorrhagic Shock clinical trials

View clinical trials related to Hemorrhagic Shock.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06311903 Recruiting - Hemorrhagic Shock Clinical Trials

Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The aim of this work was to investigate the effects of low dose of norepinephrine in preperiod of hypotensive resuscitation in hemorrhagic shock.

NCT ID: NCT06270615 Recruiting - Wounds and Injuries Clinical Trials

Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model

SHOCKMATRIX
Start date: July 1, 2022
Phase:
Study type: Observational

Management of post-traumatic severe hemorrhage remains a challenge to any trauma care system. Studying integrated and innovative tools designed to predict the risk of early severe hemorrhage (ESH) and resource needs could offer a promising option to improve clinical decisions and then shorten the time of intervention in the context of pre-hospital severe trauma. As evidence seems to be lacking to address this issue, this ambispective validation study proposes to assess on an independent cohort the predictive performance of a newly developed machine learning-based model, as well as the feasibility of its clinical deployment under real-time healthcare conditions.

NCT ID: NCT04684719 Recruiting - Hemorrhagic Shock Clinical Trials

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

TOWAR
Start date: April 19, 2022
Phase: Phase 3
Study type: Interventional

Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize the hemostatic competency of whole blood relative to its age.

NCT ID: NCT04610814 Recruiting - Hemorrhagic Shock Clinical Trials

Blood Transfusion by Boston MedFlight Registry

Start date: November 1, 2019
Phase:
Study type: Observational [Patient Registry]

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

NCT ID: NCT03406598 Recruiting - Sepsis Clinical Trials

Bedside Visual Analysis of Sublingual Microcirculation in Shock Patients

MICROEYE
Start date: March 2, 2018
Phase:
Study type: Observational

In shock patients, fluid resuscitation, infusion of vasopressors and transfusion are guided on hemodynamic macrovascular parameters. Analysis of sublingual microcirculation in shock patients is predictive of mortality and organ dysfunction. To optimize the quality of the resuscitation in shock patients, it could be useful to have an assessment of sublingual microcirculation in addition to the macrovascular parameters usually assessed by the nurses. But, this requires to have a monitor of sublingual microcirculation easy to use and to analyze at the bedside. The primary outcome of the present study is to test the ability of visual analysis of sublingual microcirculation by nurses to predict needs for fluid challenge, vasopressors or transfusion in patients in shock. After ICU admission and study inclusion, the nurses in charge of the patient will perform a set of measurements of macrocirculatory and microcirculatory parameters every 4 h during the first three days after ICU admission and before and after every hemodynamic therapeutic intervention, such as fluid challenge, transfusion of red blood cells or change in catecholamine rate. The secondary outcomes are to test 1/ to test the ability of visual analysis of sublingual microcirculation to predict organ dysfunction (SOFA score), and 2/ to evaluate the relationship between hemodynamic macrovascular and microvascular parameters. Intensive care patients in shock who need sedation, mechanical ventilation and invasive hemodynamic monitoring (Pulse Contour Cardiac Output (PiCCO 2 device)) will be included. In addition, patients will be included only when patients will obviously stay more than 24 hours in the ICU.

NCT ID: NCT03235921 Recruiting - Hemorrhagic Shock Clinical Trials

Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock

Start date: March 2016
Phase: Phase 2
Study type: Interventional

Hemorrhagic shock is a pathologic state in which intravascular volume and oxygen delivery are impaired. During circulatory failure associated with hypovolemia and low cardiac output, redistribution of blood flow caused by increased vasoconstriction results in decreased perfusion of the skin. Skin temperature and capillary refill time has been advocated as a measure of peripheral perfusion.

NCT ID: NCT00459160 Recruiting - Trauma Clinical Trials

A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients

Start date: July 2007
Phase: N/A
Study type: Interventional

The goal of this study will be to determine if a lower than normal blood pressure during surgery for bleeding in the abdomen or chest will result in decreased bleeding and decreased chance of death.